Abstract
Oxidative stress in liver injury is a major pathogenetic factor in progress of liver fibrosis. Resveratrol, a representative antioxidant derived from grapes, has been reported to show widespread pharmacological properties. In this study, we investigated the protective effects of resveratrol on dimethylnitrosamine (DMN)-induced liver fibrosis in rats. Rats were treated with resveratrol daily by oral gavage for seven days after a single intraperitoneal injection of DMN (40 mg/kg). Resveratrol remarkably recovered body and liver weight loss due to DMNinduced liver fibrosis. Liver histology showed that resveratrol alleviated the infiltration of inflammatory cells and fibrosis of liver tissue. Resveratrol decreased the level of malondialdehyde and increased the levels of glutathione peroxidase and superoxide dismutase. Also, resveratrol significantly inhibited the mRNA expression of inflammatory mediators including inducible nitric oxide, tumor necrosis factor-alpha and interleukin-1beta. In addition, resveratrol showed not only reduced mRNA expression of fibrosis-related genes such as transforming growth factor beta 1, collagen type I, and alpha-smooth muscle actin, but also a significant decrease of hydroxyproline in rats with DMN-induced liver fibrosis. Our results suggest that resveratrol could be used to treat liver injury and fibrosis and be useful in preventing the development of liver fibrosis and cirrhosis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ajmo, J. M., Liang, X., Rogers, C. Q., Pennock, B., and You, M., Resveratrol alleviates alcoholic fatty liver in mice. Am. J. Physiol. Gastrointest. Liver Physiol., 295, 833–842 (2008).
Bennett, R. G., Kharbanda, K. K., and Tuma, D. J., Inhibition of markers of hepatic stellate cell activation by the hormone relaxin. Biochem. Pharmacol., 66, 867–874 (2003).
Birrell, M. A., McCluskie, K., Wong, S., Donnelly, L. E., Barnes, P. J., and Belvisil, M. G., Resveratrol, an extract of red wine, inhibits lipopolysaccharide induced airway neutrophilia and inflammatory mediators through an NFkappa B-independent mechanism. FASEB J., 19, 840–841 (2005).
Bisht, K., Wagner, K. H., and Bulmer, A. C., Curcumin, resveratrol and flavonoids as anti-inflammatory, cyto- and DNA-protective dietary compounds. Toxicology, Epub ahead of print (2009).
Breitkopf, K., Sawitza, I., and Gressner, A. M., Characterization of intracellular pathways leading to coinduction of thrombospondin-1 and TGF-beta1 expression in rat hepatic stellate cells. Growth Factors, 23, 77–85 (2005).
Bujanda, L., Hijona, E., Larzabal, M., Beraza, M., Aldazabal, P., Garcia-Urkia, N., Sarasqueta, C., Cosme, A., Irastorza, B., Gonzalez, A., and Arenas, J. I., Jr., Resveratrol inhibits nonalcoholic fatty liver disease in rats. BMC Gastroenterol., 8, 35 (2008).
Cai, Y. J., Fang, J. G., Ma, L. P., Yang, L., and Liu, Z. L., Inhibition of free radical-induced peroxidation of rat liver microsomes by resveratrol and its analogues. Biochim. Biophys. Acta, 1637, 313–318 (2003).
Caro, A. A. and Cederbaum, A. I., Oxidative stress, toxicology, and pharmacology of CYP2E1. Annu. Rev. Pharmacol. Toxicol., 44, 27–42 (2004).
Casini, A., Ceni, E., Salzano, R., Milani, S., Schuppan, D., and Surrenti, C., Acetaldehyde regulates the gene expression of matrix-metalloproteinase-1 and -2 in human fat-storing cells. Life Sci., 55, 1311–1316 (1994).
Chavez, E., Reyes-Gordillo, K., Segovia, J., Shibayama, M., Tsutsumi, V., Vergara, P., Moreno, M. G., and Muriel, P., Resveratrol prevents fibrosis, NF-kappa B activation and TGF-beta increases induced by chronic CCl4 treatment in rats. J. Appl. Toxicol., 28, 35–43 (2008).
Chen, A. and Zhang, L., The antioxidant (-)-epigallocatechin-3-gallate inhibits rat hepatic stellate cell proliferation in vitro by blocking the tyrosine phosphorylation and reducing the gene expression of platelet-derived growth factorbeta receptor. J. Biol. Chem., 278, 23381–23389 (2003).
Cressman, D. E., Greenbaum, L. E., DeAngelis, R. A., Ciliberto, G., Furth, E. E., Poli, V., and Taub, R., Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science, 274, 1379–1383 (1996).
Donnelly, L. E., Newton, R., Kennedy, G. E., Fenwick, P. S., Leung, R. H., Ito, K., Russell, R. E., and Barnes, P. J., Anti-inflammatory effects of resveratrol in lung epithelial cells: molecular mechanisms. Am. J. Physiol. Lung Cell Mol. Physiol., 287, L774–L783 (2004).
Ezquerro, I. J., Lasarte, J. J., Dotor, J., Castilla-Cortazar, I., Bustos, M., Penuelas, I., Blanco, G., Rodriguez, C., Lechuga Mdel, C., Greenwel, P., Rojkind, M., Prieto, J., and Borras-Cuesta, F., A synthetic peptide from transforming growth factor beta type III receptor inhibits liver fibrogenesis in rats with carbon tetrachloride liver injury. Cytokine, 22, 12–20 (2003).
Friedman, S. L., Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J. Biol. Chem., 275, 2247–2250 (2000).
George, J., Rao, K. R., Stern, R., and Chandrakasan, G., Dimethylnitrosamine-induced liver injury in rats: the early deposition of collagen. Toxicology, 156, 129–138 (2001).
Godichaud, S., Krisa, S., Couronne, B., Dubuisson, L., Merillon, J. M., Desmouliere, A., and Rosenbaum, J., Deactivation of cultured human liver myofibroblasts by trans-resveratrol, a grapevine-derived polyphenol. Hepatology, 31, 922–931 (2000).
Hierholzer, C., Harbrecht, B., Menezes, J. M., Kane, J., Macmicking, J., Nathan, C. F., Peitzman, A. B., Billiar, T. R., and Twardy, D. J., Essential role of induced nitric oxide in the initiation of the inflammatory response after hemorrhagic shock. J. Exp. Med., 187, 917–928 (1998).
Jamall, I. S., Finelli, V. N., and Que Hee, S. S., A simple method to determine nanogram levels of 4-hydroxyproline in biological tissues. Anal. Biochem., 112, 70–75 (1981).
Jaeschke, H., Reactive oxygen and mechanisms of inflammatory liver injury., J. Gastroenterol. Hepatol., 15, 718–724 (2000).
Kasdallah-Grissa, A., Mornagui, B., Aouani, E., Hammami, M., El May, M., Gharbi, N., Kamoun, A., and El-Fazaa, S., Resveratrol, a red wine polyphenol, attenuates ethanolinduced oxidative stress in rat liver. Life Sci., 80, 1033–1039 (2007).
Kim, K. Y., Rhim, T., Choi, I., and Kim, S. S., N-acetylcysteine induces cell cycle arrest in hepatic stellate cells through its reducing activity. J. Biol. Chem., 276, 40591–40598 (2001).
Leonard, S. S., Xia, C., Jiang, B. H., Stinefelt, B., Klandorf, H., Harris, G. K., and Shi, X., Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses. Biochem. Biophys. Res. Commun., 309, 1017–1026 (2003).
Lopez-Velez, M., Martinez-Martinez, F., and Del Valle-Ribes, C., The study of phenolic compounds as natural antioxidants in wine. Crit. Rev. Food Sci. Nutr., 43, 233–244 (2003).
Ma, Z. H., Ma, Q. Y., Wang, L. C., Sha, H. C., Wu, S. L., and Zhang, M., Effect of resveratrol on peritoneal macrophages in rats with severe acute pancreatitis. Inflamm. Res., 54, 522–527 (2005).
Malinski, J. A., Zera, E. M., Angleson, J. K., and Wensel, T. G., High affinity interactions of GTPgammaS with the heterotrimeric G protein, transducin. Evidence at high and low protein concentrations. J. Biol. Chem., 271, 12919–12924 (1996).
Niehaus, W. G., Jr. and Samuelsson, B., Formation of malonaldehyde from phospholipid arachidonate during microsomal lipid peroxidation. Eur. J. Biochem., 6, 126–130 (1968).
Nordmann, R., Alcohol and antioxidant systems. Alcohol Alcohol., 29, 513–522 (1994).
Novo, E. and Parola, M., Redox mechanisms in hepatic chronic wound healing and fibrogenesis. Fibrogenesis Tissue Repair, 1, 5 (2008).
Ohara, F., Nii, A., Sakiyama, Y., Tsuchiya, M., and Ogawa, S., Pathophysiological characteristics of dimethylnitrosamine-induced liver fibrosis in acute and chronic injury models: a possible contribution of KLF5 to fibrogenic responses. Dig. Dis. Sci., 53, 2222–2232 (2008).
Pinzani, M. and Marra, F., Cytokine receptors and signaling in hepatic stellate cells. Semin. Liver Dis., 21, 397–416 (2001).
Ramadori, G. and Armbrust T., Cytokines in the liver. Eur. J. Gastroenterol. Hepatol., 13, 777–784 (2001).
Rivera, H., Shibayama, M., Tsutsumi, V., Perez-Alvarez, V., and Muriel, P., Resveratrol and trimethylated resveratrol protect from acute liver damage induced by CCl4 in the rat. J. Appl. Toxicol., 28, 147–155 (2008).
Rushmore, T. H. and Kong, A. N., Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes. Curr. Drug Metab., 3, 481–490 (2002).
Shang, J., Chen, L., Xiao, F., Sun, H., Ding, H., and Xiao, H., Resveratrol improves non-alcoholic fatty liver disease by activating AMP activated protein kinase. Acta Pharmacol. Sin., 29, 698–706 (2008).
Seifert, W. F., Bosma, A., Hendriks, H. F., Van Leeuwen, R. E., Van Thiel-de Ruiter, G. C., Seifert-Bock, I., Knook, D. L., and Brouwer, A., Beta-carotene (provitamin A) decreases the severity of CCl4-induced hepatic inflammation and fibrosis in rats. Liver, 15, 1–8 (1995).
Shafritz, D. A., Oertel, M., Menthena, A., Nierhoff, D., and Dabeva, M. D., Liver stem cells and prospects for liver reconstitution by transplanted cells. Hepatology, 43, S89–S98 (2006).
Shiba, M., Shimizu, I., Yasuda, M., Ii, K., and Ito, S., Expression of type I and type III collagens during the course of dimethylnitrosamine-induced hepatic fibrosis in rats. Liver, 18, 196–204 (1998).
Sohara, N., Znoyko, I., Levy, M. T., Trojanowska, M., and Reuben, A., Reversal of activation of human myofibroblast-like cells by culture on a basement membrane-like substrate. J. Hepatol., 37, 214–221 (2002).
Tilg, H. and Diehl, A. M., Cytokines in alcoholic and nonalcoholic steatohepatitis. N. Engl. J. Med., 343, 1467–1476 (2000).
Wallace, J. D. and Levy, L. L., Blood pressure after stroke. JAMA, 246, 2177–2180 (1981).
Weber, L. W., Boll, M., and Stampfl, A., Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model. Crit. Rev. Toxicol., 33, 105–136 (2003).
Wills, P. J., Suresh, V., Arun, M., and Asha, V. V., Antiangiogenic effect of Lygodium flexuosum against Nnitrosodiethylamine-induced hepatotoxicity in rats. Chem. Biol. Interact., 164, 25–38 (2006).
Wolter, F., Ulrich, S., and Stein, J., Molecular mechanisms of the chemopreventive effects of resveratrol and its analogs in colorectal cancer: key role of polyamines? J. Nutr., 134, 3219–3222 (2004).
Wu, L. C., Ho, J. A., Shieh, M. C., and Lu, I. W., Antioxidant and antiproliferative activities of Spirulina and Chlorella water extracts. J. Agric. Food Chem., 53, 4207–4212 (2005).
Yasuda, M., Shimizu, I., Shiba, M., and Ito, S., Suppressive effects of estradiol on dimethylnitrosamine-induced fibrosis of the liver in rats. Hepatology, 29, 719–727 (1999).
Author information
Authors and Affiliations
Corresponding author
Additional information
These authors contributed equally to this work.
Rights and permissions
About this article
Cite this article
Hong, SW., Jung, K.H., Zheng, HM. et al. The protective effect of resveratrol on dimethylnitrosamine-induced liver fibrosis in rats. Arch. Pharm. Res. 33, 601–609 (2010). https://doi.org/10.1007/s12272-010-0415-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-010-0415-y